Lanas Commits NZ$150 Million to Accelerate Healthcare Technology Growth in New Zealand

Global healthcare technology company Lanas today announced plans to invest NZ$150 million in New Zealand healthcare technology over the next two years, deepening its commitment to the country's digital health future. As part of the investment, Lanas has entered into an agreement to acquire primary care platform, indici.

The plan reflects Lanas' long-term commitment to the region and will focus on investing in the products, technologies and capabilities that support healthcare professionals every day. This includes developing and improving products, AI-enabled capabilities, infrastructure, interoperability and further opportunities to invest in the sector.

Since launching in 2017, indici is used by more than 250 healthcare organisations across New Zealand, supporting over 2 million patient records. Following completion of the transaction, indici will continue to operate with its existing customer focus and team, with day-to-day service and support continuing as usual, while benefiting from the investment, infrastructure and opportunities available as part of the wider Lanas company. Dr. Ahmad Javad, founder of indici, will continue to provide strategic advice on product direction with the Lanas team.

To date, other local investments include HealthLink, which delivers lab results and clinical messages to GPs nationwide; Toniq, a pharmacy software provider; and KonnectNET, which digitises insurance medical requests between insurers and GPs. The addition of indici expands that into general practice.

The investment comes at a pivotal time for New Zealand's health system. Health New Zealand is building a national Shared Digital Health Record, moving prescribing fully online through the NZ ePrescription Service and strengthening cybersecurity across primary care, backed by more than $450 million in digital health funding in Budget 2026. At the same time, general practices facing sustained workforce pressure need technology that reduces administration and gives clinicians more time with patients. Lanas intends to work with Health New Zealand, primary health organisations and the wider sector to support those priorities.

Commenting on the announcement, Lanas Founder & CEO, Howard Beggs said:

"We have been supporting customers across New Zealand for many years, and we continue to see opportunity for technology to play an even greater role in the future of its healthcare system.

New Zealand has a strong track record of embracing digital healthcare and a healthcare sector that is willing to innovate, collaborate and lead. That's one of the reasons we're so excited about deepening our investment here for the long term - starting with the indici transaction.

indici has built one of New Zealand's leading primary care platforms, with a strong team, deep expertise and a track record of delivering for customers. We've long admired what Dr. Javad and the team have built and we're delighted to welcome them to Lanas.

Together with HealthLink, Toniq and KonnectNET, indici further strengthens our presence across New Zealand and broadens the reach of our technology and innovation across the region. It's an important next step in delivering on our long-term plans for the New Zealand market."

Dr. Ahmad Javad, Founder of indici, said:

"indici has always been focused on helping healthcare professionals deliver better patient care through modern, cloud-based technology.
Indici joining Lanas gives the indici product access to additional investment, expertise and scale while allowing the team to remain focused on our customers.

I am excited about what this means for the future of the platform and for New Zealand's healthcare ecosystem."

Backed by TA Associates ("TA"), a leading global private equity firm, Lanas is a healthcare technology company operating across the UK, Ireland, Australia and New Zealand. The company employs approximately 900 people globally, including more than 160 people in Auckland and Christchurch, with more highly skilled employment opportunities envisaged in New Zealand as the company expands its investment in the market.

Upon completion of the transaction, Lanas' total investment in New Zealand is expected to approach NZ$200 million.

New Zealand has established itself as one of the world's most innovative healthcare technology markets, producing solutions that are used by healthcare providers across the country and increasingly around the world. Lanas' investment reflects its confidence in New Zealand's ability to remain at the forefront of healthcare technology, supported by continued investment in product innovation, interoperability, AI and the digital infrastructure that underpins modern healthcare.

The transaction will close following the standard regulatory process in NZ.